Skip to main content
Clinical Trials/NCT00268138
NCT00268138UnknownPhase 4

Phase 4 Study Prevention of Incipient Carious Lesions (White Spot Lesions) in Patients With Fixed Orthodontic Appliances Following the Application of Elmex Gel

Hadassah Medical Organization4 sites in 2 countries314 target enrollmentStarted: April 1, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
314
Locations
4
Primary Endpoint
time and frequency of visually detected WSL (white spot lesions)

Study Overview

Brief Summary

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Detailed Description

314 healthy subjects undergoing orthodontic treatment will be examined. follow up will take place from bonding the appliance till debonding, at least 12 months and no more than 30 months.

tooth brushing with product (test product or control) once per week during the entire study.

4 times a year additional tray application of test product or control. subjects wiil clean their teeth with the toothpaste they usually use during the entire study.

toothbrush and a sandglass will be provided every 6 weeks

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
10 Years to 60 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • treatment plan: minimum of 10 teeth to be bonded labially at least 10 years old
  • written declaration of informed consent

Exclusion Criteria

  • known allergy to components of test products
  • handicapped patients who have difficulties brushing their teeth
  • pathological desquamation changes
  • known pregnancy, breast feeding
  • eating disorders
  • disease that effect dental hard tissue
  • participation in another clinical trial either currently or within the lase 30 days

Outcomes

Primary Outcomes

time and frequency of visually detected WSL (white spot lesions)

Time Frame: 3 month

Secondary Outcomes

  • mineral loss according to QLF readings(3 month)
  • Frequency and chronoloy of WSL(3 month)

Investigators

Sponsor Class
Other

Study Sites (4)

Loading locations...

Similar Trials